But the US says it has no medicinal use...
Cannabis medicines could hit UK next year
Preliminary results from GW’s four randomised, double-blind, placebo-controlled Phase III trials show significant reductions in neuropathic (nerve-damage) pain, spasticity and sleep disturbance in patients with the nerve wasting disease multiple sclerosis, reported the company.
The company said that the benefits seen in all four studies are even better than those obtained with standard prescription medicines (patients receiving both active and placebo medicines continued to take their standard prescription medicines during the trial).
posted by Cyndy
| link
|
|
|
Home